Alice Egerton
Overview
Explore the profile of Alice Egerton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
2944
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Livingston N, De Micheli A, McCutcheon R, Butler E, Hamdan M, Grace A, et al.
medRxiv
. 2023 Aug;
PMID: 37645948
Background: Animal models indicate GABAergic dysfunction in the development of psychosis, and that benzodiazepine (BDZ) exposure can prevent the emergence of psychosis-relevant phenotypes. However, whether BDZ exposure influences the risk...
12.
Jauhar S, McCutcheon R, Veronese M, Borgan F, Nour M, Rogdaki M, et al.
Transl Psychiatry
. 2023 May;
13(1):184.
PMID: 37253720
The neuromodulator dopamine and excitatory neurotransmitter glutamate have both been implicated in the pathogenesis of psychosis, and dopamine antagonists remain the predominant treatment for psychotic disorders. To date no study...
13.
Fenn-Moltu S, Deakin B, Drake R, Howes O, Lawrie S, Lewis S, et al.
Brain Behav Immun
. 2023 May;
111:343-351.
PMID: 37182555
Glutamate and increased inflammation have been separately implicated in the pathophysiology of schizophrenia and the extent of clinical response to antipsychotic treatment. Despite the mechanistic links between pro-inflammatory and glutamatergic...
14.
Nordio G, Easmin R, Giacomel A, Dipasquale O, Martins D, Williams S, et al.
J Cereb Blood Flow Metab
. 2023 Apr;
43(8):1285-1300.
PMID: 37026455
In this study we evaluate the performance of a fully automated analytical framework for FDOPA PET neuroimaging data, and its sensitivity to demographic and experimental variables and processing parameters. An...
15.
Oliver D, Davies C, Zelaya F, Selvaggi P, De Micheli A, Catalan A, et al.
Front Psychiatry
. 2023 Mar;
14:1092213.
PMID: 36970257
Introduction: The impact of the clinical high-risk for psychosis (CHR-P) construct is dependent on accurately predicting outcomes. Individuals with brief limited intermittent psychotic symptoms (BLIPS) have higher risk of developing...
16.
Susai S, Focking M, Mongan D, Heurich M, Coutts F, Egerton A, et al.
Schizophr Bull
. 2023 Mar;
49(4):893-902.
PMID: 36916850
Background And Hypothesis: Treatment response to specific antipsychotic medications is difficult to predict on clinical grounds alone. The current study hypothesizes that the baseline complement pathway activity predicts the treatment...
17.
Merritt K, McCutcheon R, Aleman A, Ashley S, Beck K, Block W, et al.
Mol Psychiatry
. 2023 Feb;
28(5):2039-2048.
PMID: 36806762
Glutamatergic dysfunction is implicated in schizophrenia pathoaetiology, but this may vary in extent between patients. It is unclear whether inter-individual variability in glutamate is greater in schizophrenia than the general...
18.
Zahid U, Onwordi E, Hedges E, Wall M, Modinos G, Murray R, et al.
Neurosci Biobehav Rev
. 2022 Dec;
144:105010.
PMID: 36549375
Glutamatergic and GABAergic dysfunction are implicated in the pathophysiology of schizophrenia. Previous work has shown relationships between glutamate, GABA, and brain activity in healthy volunteers. We conducted a systematic review...
19.
Egerton A, Griffiths K, Casetta C, Deakin B, Drake R, Howes O, et al.
Neuropsychopharmacology
. 2022 Dec;
48(3):567-575.
PMID: 36456813
Elevated brain glutamate has been implicated in non-response to antipsychotic medication in schizophrenia. Biomarkers that can accurately predict antipsychotic non-response from the first episode of psychosis (FEP) could allow stratification...
20.
Millgate E, Griffiths K, Egerton A, Kravariti E, Casetta C, Deakin B, et al.
BMJ Open
. 2022 Nov;
12(11):e062570.
PMID: 36410817
Objectives: This prospective cohort study tested for associations between baseline cognitive performance in individuals early within their first episode and antipsychotic treatment of psychosis. We hypothesised that poorer cognitive functioning...